Antioxidant enzyme activity and coronary heart disease: meta-analyses of observational studies

Gemma Flores-Mateo1, Paloma Carrillo-Santisteve, Roberto Elosua

  • 1Primary Care Centres Research Institut Jordi Gol, Barcelona, Spain.

Insights

Higher levels of antioxidant enzymes, including glutathione peroxidase, superoxide dismutase, and catalase, are linked to a reduced risk of coronary heart disease (CHD). This meta-analysis confirms a protective association, suggesting potential therapeutic targets for CHD prevention.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Preventive Cardiology

Background:

  • Conflicting data exist regarding the association between scavenger antioxidant enzyme activity and coronary heart disease (CHD) risk.
  • Antioxidant enzymes play a crucial role in cellular defense against oxidative stress, a known contributor to cardiovascular pathology.

Purpose of the Study:

  • To conduct updated meta-analyses evaluating the relationship between the activities of glutathione peroxidase, superoxide dismutase, and catalase and CHD risk.
  • To synthesize evidence from existing studies to clarify the role of these enzymes in CHD pathogenesis and prevention.

Main Methods:

  • Comprehensive literature searches (January 1966-January 2008) using computer-based and manual methods.
  • Inclusion of case-control and prospective studies measuring antioxidant enzyme activities and clinical CHD outcomes.
  • Calculation of pooled odds ratios using an inverse-variance-weighted random-effects model to assess CHD risk associated with enzyme activity levels.

Main Results:

  • Inclusion of 42 case-control and 3 prospective studies.
  • Significant inverse associations were found: a 1-SD increase in activity was linked to reduced CHD risk (GPx: OR 0.51, SD: OR 0.48, CAT: OR 0.32).
  • High between-study heterogeneity (I(2) > 90%) was observed, though findings remained robust in sensitivity analyses.

Conclusions:

  • The meta-analyses support a significant inverse association between circulating levels of superoxide dismutase, glutathione peroxidase, and catalase activities and CHD.
  • These findings highlight the potential cardioprotective role of these antioxidant enzymes.
  • Further high-quality prospective studies are warranted to confirm these associations and explore underlying mechanisms.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...